Modulation of aromatase by phytoestrogens

Enzyme Research

Volumn 2015, Issue , 2015, Pages

  Lephart, Edwin D ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; MESSENGER RNA; PHYTOESTROGEN;

ANTINEOPLASTIC ACTIVITY; AROMATASE GENE; AROMATIZATION; BREAST CANCER; CELL PROLIFERATION; CHEMICAL STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; HORMONE ACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SCREENING TEST; STRUCTURE ACTIVITY RELATION; TISSUE SPECIFICITY;

EID: 84954515291     PISSN: 20900406     EISSN: 20900414     Source Type: Journal    
DOI: 10.1155/2015/594656     Document Type: Review

References (104)

1. G. Di Nardo and G. Gilardi, "Human aromatase: perspectives in biochemistry and biotechnology, " Biotechnology and Applied Biochemistry, vol. 60, no. 1, pp. 92-101, 2013.
2. R. J. Santen, H. Brodie, E. R. Simpson, P. K. Siiteri, and A. Brodie, "History of aromatase: saga of an important biological mediator and therapeutic target, " Endocrine Reviews, vol. 30, no. 4, pp. 343-375, 2009.
3. C. Stocco, "Tissue physiology and pathology of aromatase, " Steroids, vol. 77, no. 1-2, pp. 27-35, 2012.
4. C. Taxvig, A. Elleby, K. Sonne-Hansen et al. , "Effects of nutrition relevant mixtures of phytoestrogens on steroidogenesis, aromatase, estrogen, and androgen activity, " Nutrition and Cancer, vol. 62, no. 1, pp. 122-131, 2010.
5. H. Adlercreutz, C. Bannwart, K. Wahala et al. , "Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens, " Journal of Steroid Biochemistry and Molecular Biology, vol. 44, no. 2, pp. 147-153, 1993.
6. H. Adlercreutz and W. Mazur, "Phyto-oestrogens and Western diseases, " Annals of Medicine, vol. 29, no. 2, pp. 95-120, 1997.
7. P. DeCremoux andY. Jacquot, "Isoflavones and human estrogen receptor: when plants synthesis mammalian hormone minetics, " in Isoflavones: Chemistry, Analysis, Function and Effects, V. R. Preedy, Ed. , pp. 157-178, The Royal Society of Chemistry, Cambridge, UK, 2013.
8. S. Karkola and K. Wahala, "The binding of lignans, flavonoids and coumestrol to CYP450 aromatase: a molecular modelling study, " Molecular and Cellular Endocrinology, vol. 301, no. 1-2, pp. 235-244, 2009.
9. D. Ingram, K. Sanders, M. Kolybaba, and D. Lopez, "Casecontrol study of phyto-oestrogens and breast cancer, " The Lancet, vol. 350, no. 9083, pp. 990-994, 1997.
10. C. L. Smith, "Estrogens, overview, " in Encyclopedia of Reproduction, E. Knobil and J. D. Neill, Eds. , vol. 2, pp. 119-126, Academic Press, New York, NY, USA, 1999.
11. A. S. Meyer, "Conversion of 19-hydroxy-δ4-androstene-3, 17-dione to estrone by endocrine tissue, " Biochimica et Biophysica Acta, vol. 17, pp. 441-442, 1955.
12. A. S. Meyer, M. Hayano, M. C. Lindberg, M. Gutt, and O. G. Rogers, "The conversion of δ4-androstene-3, 17-dione-4-C14 and dehydroepiandrosterone by bovine adrenal homogenate preparations, " Acta Endocrinologica, vol. 18, no. 2, pp. 148-168, 1955.
13. K. J. Ryan, "Biological aromatization of steroids, " The Journal of Biological Chemistry, vol. 234, no. 2, pp. 268-272, 1959.
14. E. A. Thompson Jr. and P. K. Siiteri, "Theinvolvement of human placental microsomal cytochrome P-450 in aromatization, " The Journal of Biological Chemistry, vol. 249, no. 17, pp. 5373-5378, 1974.
15. J. M. Grodin, P. K. Siiteri, and P. C. MacDonald, "Source of estrogen production in postmenopausal women, "The Journal of Clinical Endocrinology&Metabolism, vol. 36, no. 2, pp. 207-214, 1973.
16. D. L. Hemsell, C. D. Edman, J. F. Marks, P. K. Siiteri, and P. C. MacDonald, "Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy, " The Journal of Clinical Investigation, vol. 60, no. 2, pp. 455-464, 1977.
17. W. C. Boon, J. D. Y. Chow, and E. R. Simpson, "The multiple roles of estrogens and the enzyme aromatase, " Progress in Brain Research, vol. 181, pp. 209-232, 2010.
18. D. Ghosh, J. Griswold, M. Erman, and W. Pangborn, "Structural basis for androgen specificity and oestrogen synthesis in human aromatase, " Nature, vol. 457, no. 7226, pp. 219-223, 2009.
19. A. Kamat, M. M. Hinshelwood, B. A. Murry, and C. R. Mendelson, "Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans, " Trends in Endocrinology and Metabolism, vol. 13, no. 3, pp. 122-128, 2002.
20. E. D. Lephart, "A review of brain aromatase cytochrome P450, " Brain Research Reviews, vol. 22, no. 1, pp. 1-26, 1996.
21. R. A. Lobo, S. R. Davis, T. J. De Villiers et al. , "Prevention of diseases after menopause, " Climacteric, vol. 17, no. 5, pp. 540-556, 2014.
22. D. A. Marsh, H. J. Brodie, W. Garrett, C.-H. Tsai-Morris, and A. M. H. Brodie, "Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives, " Journal of Medicinal Chemistry, vol. 28, no. 6, pp. 788-795, 1985.
23. J. L. Olin and M. St. Pierre, "Aromatase inhibitors in breast cancer prevention, " Annals of Pharmacotherapy, vol. 48, no. 12, pp. 1605-1610, 2014.
24. E. R. Simpson, C. Clyne, G. Rubin et al. , "Aromatase-a brief overview, " Annual Review of Physiology, vol. 64, pp. 93-127, 2002.
25. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy, "Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies, " The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 230S-242S, 2005.
26. C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez, "Polyphenols: food sources and bioavailability, " The American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 727-747, 2004.
27. E. K. Cheruiyot, L. M. Mumera, W. K. Ngetich, A. Hassanali, and F. Wachira, "Polyphenols as potential indicators for drought tolerance in tea (Camellia sinensis L. ), " Bioscience, Biotechnology and Biochemistry, vol. 71, no. 9, pp. 2190-2197, 2007.
28. N. Salah, N. J. Miller, G. Paganga, L. Tijburg, G. P. Bolwell, and C. Rice-Evans, "Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants, " Archives of Biochemistry and Biophysics, vol. 322, no. 2, pp. 339-346, 1995.
29. J. P. E. Spencer, M. M. Abd El Mohsen, A.-M. Minihane, and J. C. Mathers, "Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research, " British Journal of Nutrition, vol. 99, no. 1, pp. 12-22, 2008.
30. C.-M. Liu, C.-Y. Chen, and Y.-W. Lin, "Estimation of tea catechin levels using micellar electrokinetic chromatography: a quantitative approach, " Food Chemistry, vol. 150, pp. 145-150, 2014.
31. M. S. Butt, A. Imran, M. K. Sharif et al. , "Black tea polyphenols: a mechanistic treatise, " Critical Reviews in Food Science and Nutrition, vol. 54, no. 8, pp. 1002-1011, 2014.
32. M. Meydani and S. T. Hasan, "Dietary polyphenols and obesity, " Nutrients, vol. 2, no. 7, pp. 737-751, 2010.
33. S. Khurana, K. Venkataraman, A. Hollingsworth, M. Piche, and T. C. Tai, "Polyphenols: benefits to the cardiovascular system in health and in aging, " Nutrients, vol. 5, no. 10, pp. 3779-3827, 2013.
34. S. Wang, N. Moustaid-Moussa, L. Chen et al. , "Novel insights of dietary polyphenols and obesity, " The Journal of Nutritional Biochemistry, vol. 25, no. 1, pp. 1-18, 2014.
35. J. A. Evans and E. J. Johnson, "The role of phytonutrients in skin health, " Nutrients, vol. 2, no. 8, pp. 903-928, 2010.
36. M. J. Takaoka, "Of the phenolic substances of white hellebore (Veratrum gandiflorum Loes. fil. ), " Journal of the Faculty of Science, Hokkaido University, vol. 3, pp. 1-16, 1940.
37. S. Nonomura, H. Kanagawa, and A. Makimoto, "Chemical constituents of polygonaceous plants. I. Studies on the components of Koj O-Kon. (Polygonum Cuspidatum Sieb. Et Zucc. ), " Yakugaku Zasshi, vol. 83, pp. 988-990, 1963.
38. E. H. Siemann and L. L. Creasy, "Concentration of the phytoalexin resveratrol in wine, " American Journal of Enology and Viticulture, vol. 43, pp. 49-52, 1992.
39. A. A. E. Bertelli, L. Giovannini, D. Giannessi et al. , "Antiplatelet activity of synthetic and natural resveratrol in red wine, " International Journal of Tissue Reactions, vol. 17, no. 1, pp. 1-3, 1995.
40. M. Jang, L. Cai, G. O. Udeani et al. , "Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, " Science, vol. 275, no. 5297, pp. 218-220, 1997.
41. J. Tome-Carneiro, M. Larrosa, A. Gonzalez-Sarrias, F. A. Tomas-Barberan, M. T. Garcia-Conesa, and J. C. Espin, "Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence, " Current Pharmaceutical Design, vol. 19, no. 34, pp. 6064-6093, 2013.
42. J. M. Pezzuto, "The phenomenon of resveratrol: redefining the virtues of promiscuity, " Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 123-130, 2011.
43. Y. Y. Lam, C. M. Peterson, and E. Ravussin, "Resveratrol and calorie restriction: data fromrodents to humans, " Experimental Gerontology, vol. 48, no. 10, pp. 1018-1024, 2013.
44. B. Turan, E. Tuncay, and G. Vassort, "Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies, " Journal of Bioenergetics and Biomembranes, vol. 44, no. 2, pp. 281-296, 2012.
45. J. K. Bhatt, S. Thomas, and M. J. Nanjan, "Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus, " Nutrition Research, vol. 32, no. 7, pp. 537-541, 2012.
46. J. P. Crandall, V. Oram, G. Trandafirescu et al. , "Pilot study of resveratrol in older adults with impaired glucose tolerance, " The Journals of Gerontology A: Biological Sciences & Medical Sciences, vol. 67, no. 12, pp. 1307-1312, 2012.
47. E.-J. Park and J. M. Pezzuto, "Thepharmacology of resveratrol in animals and humans, " Biochimica et Biophysica Acta, vol. 1852, pp. 1071-1113, 2015.
48. K. D. R. Setchell and C. Clerici, "Equol: history, chemistry, and formation, " The Journal of Nutrition, vol. 140, no. 7, pp. 1355s-1362s, 2010.
49. E. D. Lephart, "Isoflavones and prenatal exposure to equol, " in Isoflavones: Chemistry, Analysis, Function and Effects, V. R. Preedy, Ed. , pp. 480-499, The Royal Society of Chemistry, Cambridge, UK, 2013.
50. T. D. Lund, C. Blake, L. Bu, A. N. Hamaker, and E. D. Lephart, "Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivo evidence, " Reproductive Biology and Endocrinology, vol. 9, article 4, 2011.
51. R. Gopaul, H. E. Knaggs, and E. D. Lephart, "Biochemical investigation and gene analysis of equol: a plant and soy-derived isoflavonoid with antiaging and antioxidant properties with potential human skin applications, " Biofactors, vol. 38, no. 1, pp. 44-52, 2012.
52. E. D. Lephart, "Protective effects of equol and their polyphenolic isomers against dermal aging: microarray/protein evidence with clinical implications and unique delivery into human skin, " Pharmaceutical Biology, vol. 51, no. 11, pp. 1393-1400, 2013.
53. B. R. Goldin, H. Adlercreutz, J. T. Dwyer, L. Swenson, J. H. Warram, and S. L. Gorbach, "Effect of diet on excretion of estrogens in premenopausal and post-menopausal women, " Cancer Research, vol. 9, pp. 3771-3773, 1981.
54. B. R. Goldin, H. Adlercreutz, S. L. Gorbach et al. , "Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women, " The New England Journal of Medicine, vol. 307, no. 25, pp. 1542-1547, 1982.
55. H. Aldercreutz, "Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the fiber hypothesis, " Gastroenterology, vol. 86, no. 4, pp. 761-764, 1984.
56. B. R. Goldin, H. Adlercreutz, A. S. L. Gorbach et et al. , "The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women, " The American Journal of Clinical Nutrition, vol. 44, no. 6, pp. 945-953, 1986.
57. M. Axelson, J. Sjovall, B. E. Gustaffson, and K. D. R. Setchell, "Soya-a dietary source of the non-steroidal oestrogen equol in man and animals, " Journal of Endocrinology, vol. 102, no. 1, pp. 49-56, 1984.
58. K. D. R. Setchell, S. P. Borriello, P. Hulme, D. N. Kirk, and M. Axelson, "Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease, " The American Journal of Clinical Nutrition, vol. 40, no. 3, pp. 569-578, 1984.
59. H. Adlercreutz, "Diet, breast cancer, and sex hormone metabolism, " Annals of the New York Academy of Sciences, vol. 595, pp. 281-290, 1990.
60. J. T. Kellis Jr. and L. E. Vickery, "Inhibition of human estrogen synthetase (aromatase) by flavones, " Science, vol. 225, no. 4666, pp. 1032-1034, 1984.
61. D. R. Campbell and M. S. Kurzer, "Flavonoid inhibition of aromatase enzyme activity in human preadipocytes, " Journal of Steroid Biochemistry and Molecular Biology, vol. 46, no. 3, pp. 381-388, 1993.
62. C. F. Wang, T. Makela, T. Hase, H. Adlercreutz, and M. S. Kurzer, "Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes, " Journal of Steroid Biochemistry and Molecular Biology, vol. 50, no. 3-4, pp. 205-212, 1994.
63. C. Pelissero, M. J. P. Lenczowski, D. Chinzi, B. Davail-Cuisset, J. P. Sumpter, and A. Fostier, "Effects of flavonoids on aromatase activity, an in vitro study, " Journal of Steroid Biochemistry and Molecular Biology, vol. 57, no. 3-4, pp. 215-223, 1996.
64. J. C. Le Bail, T. Laroche, F. Marre-Fournier, and G. Habrioux, "Aromatase and 17-hydroxysteroid dehydrogenase inhibition by flavonoids, " Cancer Letters, vol. 133, no. 1, pp. 101-106, 1998.
65. H.-J. Jeong, Y. G. Shin, I.-H. Kim, and J. M. Pezzuto, "Inhibition of aromatase activity by flavonoids, " Archives of Pharmacal Research, vol. 22, no. 3, pp. 309-312, 1999.
66. A.-R. Ibrahim and Y. J. Abul-Hajj, "Aromatase inhibition by flavonoids, " Journal of Steroid Biochemistry and Molecular Biology, vol. 37, no. 2, pp. 257-260, 1990.
67. J.-P. Basly andM.-C. C. Lavier, "Dietary phytoestrogens: potential selective estrogen enzymemodulators?" PlantaMedica, vol. 71, no. 4, pp. 287-294, 2005.
68. J. D. Brooks and L. U. Thompson, "Mammalian lignans and genistein decrease the activities of aromatase and 17-hydroxysteroid dehydrogenase in MCF-7 cells, " Journal of Steroid Biochemistry and Molecular Biology, vol. 94, no. 5, pp. 461-467, 2005.
69. J. A. vanMeeuwen, N. Korthagen, P. C. de Jong, A. H. Piersma, and M. van den Berg, "Antiestrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-cultures, " Toxicology and Applied Pharmacology, vol. 221, no. 3, pp. 372-383, 2007.
70. S. Rice, H. D. Mason, and S. A. Whitehead, "Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells, " Journal of Steroid Biochemistry and Molecular Biology, vol. 101, no. 4-5, pp. 216-225, 2006.
71. Y. Wang, W. M. Gho, F. I. Chan, S. Chen, and L. K. Leung, "The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression, " British Journal of Nutrition, vol. 99, no. 2, pp. 303-310, 2008.
72. S. I. Khan, J. Zhao, I. A. Khan, L. A. Walker, and A. K. Dasmahapatra, "Potential utility of natural products as regulators of breast cancer-associated aromatase promoters, " Reproductive Biology and Endocrinology, vol. 9, article 91, 2011.
73. R. J. Santen, L. M. Demers, H. Adlercreutz et al. , "Inhibition of aromatase with CGS-16949A in postmenopausal women, " Journal of Clinical Endocrinology and Metabolism, vol. 68, no. 1, pp. 99-106, 1989.
74. S. Masamura, H. Adlercreutz, H. Harvey et al. , "Aromatase inhibitor development for treatment of breast cancer, " Breast Cancer Research and Treatment, vol. 33, no. 1, pp. 19-26, 1995.
75. X. Xu, A. M. Duncan, B. E. Merz, and M. S. Kurzer, "Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women, " Cancer Epidemiology Biomarkers and Prevention, vol. 7, no. 12, pp. 1101-1108, 1998.
76. M. J. Messina, "Soy foods and soybean isoflavones and menopausal health, " Nutrition in Clinical Care, vol. 5, no. 6, pp. 272-282, 2002.
77. J. P. White and J. S. Schilling, "Postmenopausal hormone replacement: historical perspectives and current concerns, " Clinical Excellence for Nurse Practitioners, vol. 4, no. 5, pp. 277-285, 2000.
78. J. E. Rossouw, G. L. Anderson, R. L. Prentice et al. , "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the womens health initiative randomized controlled trial, " The Journal of the American Medical Association, vol. 288, no. 3, pp. 321-333, 2002.
79. L. A. Fitzpatrick, "Soy isoflavones: hope or hype?" Maturitas, vol. 44, pp. S21-S29, 2003.
80. H. Adlercreutz, "Phyto-oestrogens and cancer, " The Lancet Oncology, vol. 3, no. 6, pp. 364-373, 2002.
81. H. Adlercreutz, "Phytoestrogens and breast cancer, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 83, no. 1-5, pp. 113-118, 2002.
82. R. Mackey and R. M. Evans, "Phytoestrogens and the menopause, " Climacteric, vol. 1, no. 4, pp. 302-308, 1995.
83. M. Messerer, S.-E. Johansson, and A. Wolk, "Sociodemographic and health behaviour factors among dietary supplement and natural remedy users, " European Journal of Clinical Nutrition, vol. 55, no. 12, pp. 1104-1110, 2001.
84. S. Karkola, H.-D. Holtje, and K. Wahala, "A three-dimensional model of CYP19 aromatase for structure-based drug design, " Journal of Steroid Biochemistry and Molecular Biology, vol. 105, no. 1-5, pp. 63-70, 2007.
85. J. T. Sanderson, J. Hordijk, M. S. Denison, M. F. Springsteel, M. H. Nantz, and M. van den Berg, "Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells, " Toxicological Sciences, vol. 82, no. 1, pp. 70-79, 2004.
86. S. Paoletta, G. B. Steventon, D. Wildeboer, T. M. Ehrman, P. J. Hylands, and D. J. Barlow, "Screening of herbal constituents for aromatase inhibitory activity, " Bioorganic & Medicinal Chemistry, vol. 16, no. 18, pp. 8466-8470, 2008.
87. Y. E. Wang, T. Y. Wong, F. L. Chan, S. Chen, and L. K. Leung, "Assessing the effect of food mycotoxins on aromatase by using a cell-based system, " Toxicology in Vitro, vol. 28, no. 4, pp. 640-646, 2014.
88. J.-C. Le Bail, Y. Champavier, A.-J. Chulia, and G. Habrioux, "Effects of phytoestrogens on aromatase, 3βand 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells, " Life Sciences, vol. 66, no. 14, pp. 1281-1291, 2000.
89. M. B. M. vanDuursen, S. M. Nijmeijer, E. S. deMorree, P. C. de Jong, and M. van den Berg, "Genistein induces breast cancerassociated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model, " Toxicology, vol. 289, no. 2-3, pp. 67-73, 2011.
90. M. B. M. van Duursen, E. E. J. W. Smeets, J. C. W. Rijk, S. M. Nijmeijer, and M. van den Berg, "Phytoestrogens inmenopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model, " Toxicology and Applied Pharmacology, vol. 269, no. 2, pp. 132-140, 2013.
91. D. U. Richter, I. Mylonas, B. Toth et al. , "Effects of phytoestrogens genistein and daidzein on progesterone and estrogen (estradiol) production of human termtrophoblast cells in vitro, " Gynecological Endocrinology, vol. 25, no. 1, pp. 32-38, 2009.
92. U. Tiemann, F. Schneider, J. Vanselow, and W. Tomek, "In vitro exposure of porcine granulosa cells to the phytoestrogens genistein and daidzein: effects on the biosynthesis of reproductive steroid hormones, " Reproductive Toxicology, vol. 24, no. 3-4, pp. 317-325, 2007.
93. S. Bolca, M. Urpi-Sarda, P. Blondeel et al. , "Disposition of soy isoflavones in normal human breast tissue, " The American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 976-984, 2010.
94. X. M. Kang, Q. Y. Zhang, S. H. Wang, X. Huang, and S. Jin, "Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy, " Canadian Medical Association Journal, vol. 182, no. 17, pp. 1857-1862, 2010.
95. S. Rice and S. A. Whitehead, "Phytoestrogens oestrogen synthesis and breast cancer, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 108, no. 3-5, pp. 186-195, 2008.
96. F. Chi, R. Wu, Y.-C. Zeng, R. Xing, Y. Liu, and Z.-G. Xu, "Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies, " Asian Pacific Journal of Cancer Prevention, vol. 14, no. 4, pp. 2407-2412, 2013.
97. M. M. Liu, Y. Huang, and J. Wang, "Developing phytoestrogens for breast cancer prevention, " Anti-Cancer Agents in Medicinal Chemistry, vol. 12, no. 10, pp. 1306-1313, 2012.
98. A. V. Sirotkin and A. H. Harrath, "Phytoestrogens and their effects, " European Journal of Pharmacology, vol. 741, pp. 230-236, 2014.
99. M. Minatoya, G. Kutomi, S. Asakura et al. , "Equol, adiponectin, insulin levels and risk of breast cancer, " Asian Pacific Journal of Cancer Prevention, vol. 14, no. 4, pp. 2191-2199, 2013.
100. E. D. Lephart, "Review: anti-oxidant and anti-aging properties of equol in prostate health (BPH), " Open Journal of Endocrine and Metabolic Diseases, vol. 4, pp. 1-12, 2014.
101. V. Z. Ajdzanovic, I. M. Medigovic, J. B. Pantelic, and V. L. Milosevic, "Soy isoflavones and cellular mechanics, " Journal of Bioenergetics and Biomembranes, vol. 46, no. 2, pp. 99-107, 2014.
102. M. J. Kim, Y. J. Park, K. H. Chung, and S. M. Oh, "The inhibitory effects of the standardized extracts of Ginkgo biloba on aromatase activity in JEG-3 human choriocarcinoma cells, " Phytotherapy Research, vol. 27, no. 12, pp. 1756-1762, 2013.
103. G. Celik, H. Akca, and A. Sen, "Investigation of aromotase inhibition by several dietary vegetables in human non-small cell lung cancer cell lines, " Turkish Journal of Biochemistry, vol. 38, no. 2, pp. 207-217, 2013.
104. L. Ye, M. Y. Chan, and L. K. Leung, "The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway, " Molecular and Cellular Endocrinology, vol. 302, no. 1, pp. 73-80, 2009.